Cohance Lifesciences Limited
COHANCE
Classement en actions
#6369
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Prix de l'action
$5.05
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$1.93B
Changement (1 jour)
-1.44%
Changement (1 an)
-57.38%
Pays
IN
Échange Cohance Lifesciences Limited (COHANCE)
Catégorie
Healthcare
EPS pour Cohance Lifesciences Limited (COHANCE)
EPS au June 2025 TTM : $0.11
Selon les derniers rapports financiers et le cours de l'action de Cohance Lifesciences Limited, l’EPS actuel de la société (TTM) est de $0.11. À la fin de 2024, la société avait un EPS de $0.14 une diminution par rapport à celui de 2023, qui était de $0.20.
Historique de l'EPS de Cohance Lifesciences Limited de 2019 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2025 | $0.12 | -13.07% |
| 2024 | $0.14 | -28.03% |
| 2023 | $0.20 | -16.30% |
| 2022 | $0.23 | 20.83% |
| 2021 | $0.19 | 17.60% |
| 2020 | $0.17 | 167.48% |
| 2019 | $0.06 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
